Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
To the Editor: We thank Pham et al1 for their interest in our study on patients with atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS),2 and we appreciate the opportunity to discuss and clarify our analysis further.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of the American Academy of Dermatology |
Vol/bind | 90 |
Udgave nummer | 5 |
Sider (fra-til) | e175-e176 |
Antal sider | 2 |
ISSN | 0190-9622 |
DOI |
|
Status | Udgivet - 2024 |
ID: 385888993